Global Artificial Intelligence in IVD Market Overview:
Global Artificial Intelligence in IVD Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Artificial Intelligence in IVD Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Artificial Intelligence in IVD involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Artificial Intelligence in IVD Market:
The Artificial Intelligence in IVD Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Artificial Intelligence in IVD Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Artificial Intelligence in IVD Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Artificial Intelligence in IVD market has been segmented into:
Oncology
Infectious Disease
Cardiology
and Other Applications
By Application, Artificial Intelligence in IVD market has been segmented into:
Machine Learning
Deep Learning
and Other Technologies
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Artificial Intelligence in IVD market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Artificial Intelligence in IVD market.
Top Key Players Covered in Artificial Intelligence in IVD market are:
Abbott
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Thermo Fisher Scientific
Inc.
Danaher Corporation (Beckman Coulter)
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Artificial Intelligence in IVD Market Type
4.1 Artificial Intelligence in IVD Market Snapshot and Growth Engine
4.2 Artificial Intelligence in IVD Market Overview
4.3 Oncology
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Oncology: Geographic Segmentation Analysis
4.4 Infectious Disease
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Infectious Disease: Geographic Segmentation Analysis
4.5 Cardiology
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Cardiology: Geographic Segmentation Analysis
4.6 and Other Applications
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 and Other Applications: Geographic Segmentation Analysis
Chapter 5: Artificial Intelligence in IVD Market Application
5.1 Artificial Intelligence in IVD Market Snapshot and Growth Engine
5.2 Artificial Intelligence in IVD Market Overview
5.3 Machine Learning
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Machine Learning: Geographic Segmentation Analysis
5.4 Deep Learning
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Deep Learning: Geographic Segmentation Analysis
5.5 and Other Technologies
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 and Other Technologies: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Artificial Intelligence in IVD Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 F. HOFFMANN-LA ROCHE LTD
6.4 SIEMENS HEALTHINEERS AG
6.5 THERMO FISHER SCIENTIFIC
6.6 INC.
6.7 DANAHER CORPORATION (BECKMAN COULTER)
Chapter 7: Global Artificial Intelligence in IVD Market By Region
7.1 Overview
7.2. North America Artificial Intelligence in IVD Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Oncology
7.2.2.2 Infectious Disease
7.2.2.3 Cardiology
7.2.2.4 and Other Applications
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Machine Learning
7.2.3.2 Deep Learning
7.2.3.3 and Other Technologies
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Artificial Intelligence in IVD Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Oncology
7.3.2.2 Infectious Disease
7.3.2.3 Cardiology
7.3.2.4 and Other Applications
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Machine Learning
7.3.3.2 Deep Learning
7.3.3.3 and Other Technologies
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Artificial Intelligence in IVD Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Oncology
7.4.2.2 Infectious Disease
7.4.2.3 Cardiology
7.4.2.4 and Other Applications
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Machine Learning
7.4.3.2 Deep Learning
7.4.3.3 and Other Technologies
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Artificial Intelligence in IVD Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Oncology
7.5.2.2 Infectious Disease
7.5.2.3 Cardiology
7.5.2.4 and Other Applications
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Machine Learning
7.5.3.2 Deep Learning
7.5.3.3 and Other Technologies
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Artificial Intelligence in IVD Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Oncology
7.6.2.2 Infectious Disease
7.6.2.3 Cardiology
7.6.2.4 and Other Applications
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Machine Learning
7.6.3.2 Deep Learning
7.6.3.3 and Other Technologies
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Artificial Intelligence in IVD Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Oncology
7.7.2.2 Infectious Disease
7.7.2.3 Cardiology
7.7.2.4 and Other Applications
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Machine Learning
7.7.3.2 Deep Learning
7.7.3.3 and Other Technologies
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Artificial Intelligence in IVD Scope:
|
Report Data
|
Artificial Intelligence in IVD Market
|
|
Artificial Intelligence in IVD Market Size in 2025
|
USD XX million
|
|
Artificial Intelligence in IVD CAGR 2025 - 2032
|
XX%
|
|
Artificial Intelligence in IVD Base Year
|
2024
|
|
Artificial Intelligence in IVD Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Danaher Corporation (Beckman Coulter).
|
|
Key Segments
|
By Type
Oncology
Infectious Disease
Cardiology
and Other Applications
By Applications
Machine Learning
Deep Learning
and Other Technologies
|
